Ben Markman
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Physiology top 2%
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 8
- Lung Cancer Research Studies 6
-
- PI3K/AKT/mTOR signaling in cancer 11
- Co-authors
- Josep M. Tabernero (17 shared papers)José Baselga (7 shared papers)Rodrigo Dienstmann (3 shared papers)Maurizio Scaltriti (4 shared papers)Violeta Serra (3 shared papers)Joaquı́n Arribas (2 shared papers)Francesco Atzori (2 shared papers)Marta Guzmán (2 shared papers)
- Journals
- Annals of Oncology (17 papers)Journal for ImmunoTherapy of Cancer (4 papers)Investigational New Drugs (3 papers)Clinical Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Ben Markman
69 papers receiving 4.1k citations
Ben Markman's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.2k
- Physiology 123
- Molecular Biology 1.4k
- Cancer Research 268
- Pulmonary and Respiratory Medicine 516
Countries citing papers authored by Ben Markman
This map shows the geographic impact of Ben Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Markman more than expected).
Fields of papers citing papers by Ben Markman
This network shows the impact of papers produced by Ben Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Markman. The network helps show where Ben Markman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Markman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations Hit paper breakdown → | 2008 | 673 |
| 2 | 2011 | 468 | |
| 3 | 2010 | 295 | |
| 4 | Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer Hit paper breakdown → | 2019 | 281 |
| 5 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Hit paper breakdown → | 2020 | 184 |
| 6 | Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study Hit paper breakdown → | 2022 | 163 |
| 7 | 2018 | 154 | |
| 8 | 2020 | 141 | |
| 9 | 2009 | 138 | |
| 10 | 2012 | 125 | |
| 11 | A gut microbial signature for combination immune checkpoint blockade across cancer types Hit paper breakdown → | 2024 | 120 |
| 12 | 2020 | 119 | |
| 13 | 2019 | 102 | |
| 14 | 2016 | 100 | |
| 15 | 2010 | 99 | |
| 16 | 2020 | 97 | |
| 17 | 2014 | 91 | |
| 18 | 2011 | 70 | |
| 19 | 2017 | 68 | |
| 20 | 2021 | 48 |
About Ben Markman
Ben Markman is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 71 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Oncology (1.2k citations), Physiology (123 citations), Molecular Biology (1.4k citations), Cancer Research (268 citations) and Pulmonary and Respiratory Medicine (516 citations). Ben Markman has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Josep M. Tabernero, José Baselga, Rodrigo Dienstmann, Maurizio Scaltriti, Violeta Serra, Joaquı́n Arribas, Francesco Atzori, Marta Guzmán, Pieter J.A. Eichhorn and Sauveur-Michel Maira. Their work appears in journals such as Annals of Oncology, Journal for ImmunoTherapy of Cancer, Investigational New Drugs, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.